Found: 14
Select item for more details and to access through your institution.
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29413-2
- By:
- Publication type:
- Article
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29413-2
- By:
- Publication type:
- Article
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22362-2
- By:
- Publication type:
- Article
Atypical Presentation of Capillary Hemangioma in Oral Cavity- A Case Report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39738-1
- By:
- Publication type:
- Article
Cry Protein Crystals: A Novel Platform for Protein Delivery.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0127669
- By:
- Publication type:
- Article
Developing inhibitory peptides against SARS-CoV-2 envelope protein.
- Published in:
- PLoS Biology, 2024, v. 22, n. 3, p. 1, doi. 10.1371/journal.pbio.3002522
- By:
- Publication type:
- Article
Expression of P53 in Oral Squamous Cell Carcinoma – an IHC Study; Deep Insight into P53.
- Published in:
- Oral & Maxillofacial Pathology Journal, 2024, v. 15, n. 1, p. 61
- By:
- Publication type:
- Article
DIAGNOSTIC AND HISTOGENETIC SIGNIFICANCE OF S 100 PROTEIN IN ORAL DISEASES.
- Published in:
- Oral & Maxillofacial Pathology Journal, 2013, v. 4, n. 1, p. 302
- By:
- Publication type:
- Article
Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV‐2.
- Published in:
- AIChE Journal, 2021, v. 67, n. 12, p. 1, doi. 10.1002/aic.17440
- By:
- Publication type:
- Article
Angiogenesis in Head and Neck Cancer: An Overview.
- Published in:
- Journal of International Oral Health, 2018, v. 10, n. 5, p. 211, doi. 10.4103/jioh.jioh_192_18
- By:
- Publication type:
- Article
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 697, p. 1, doi. 10.1126/scitranslmed.adf4549
- By:
- Publication type:
- Article
An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 646, p. 1, doi. 10.1126/scitranslmed.abn6859
- By:
- Publication type:
- Article